News
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
6h
Investor's Business Daily on MSNGilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug
Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial ...
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...
In people with HIV infection, new-onset diabetes is independently predicted by higher leukocyte counts — mostly within the ...
The HIV and Faith conference is an event that will feature the premiere of the documentary 'Disrupting Stigma with Disrupting ...
Couples that were made up of 2 transgender women were less likely to contract HIV compared with couples that were made up of ...
CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's proven effectiveness ...
For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where ...
As the South marks Southern HIV/AIDS Awareness Day today, local health organizations are sounding the alarm on a persistent ...
Honesty Bishop was attacked by her cellmate. Prison officials deemed her sexually active and kept her in isolation for more than 2,000 days.
The statement noted that their efforts would undoubtedly contribute to reducing stigma, increasing awareness and ensuring ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results